A Buyer's Guide to EHR-Agnostic AI

"EHR-agnostic" has become the most overused phrase in health IT procurement. Almost every vendor claims it. Very few can back it up when you actually ask them how the integration works, who owns the data in transit, and what happens to it if the contract ends. This guide gives you the questions that separate a real EHR-agnostic architecture from a slide with the word on it.

Hospitals evaluating AI-driven workflow tools — for disposition planning, capacity management, clinical documentation, or anything else that has to read from and write to the EHR — are being asked to sign multi-year contracts on the strength of a demo. The demo will always look clean. The contract, the integration runbook, and the Business Associate Agreement (BAA) are where the real architecture shows up. This guide organizes the diligence into three areas: integration timeline, data access, and the BAA, plus a shorter section on the certifications that should back up the vendor's claims.

1. What "EHR-agnostic" actually means

A genuinely EHR-agnostic platform integrates through a standards-based interoperability layer — typically FHIR R4 APIs with SMART on FHIR authentication — rather than a bespoke interface built for one vendor's system. That distinction matters because it determines whether the same integration effort works across Epic, Oracle Health (Cerner), MEDITECH, athenahealth, or any combination your health system runs, including different EHRs across different facilities in the same IDN.

Ask the vendor to show you, not tell you. A vendor that's genuinely EHR-agnostic can describe its integration in EHR-neutral terms — data model, API standard, authentication flow — without ever naming a specific vendor's proprietary interface engine. If the answer to "how do you integrate" starts with the name of one EHR's custom toolkit, the "agnostic" part is marketing, not architecture.

Ask this	Why it matters
What interoperability standard does the integration use — FHIR R4, HL7v2, a proprietary interface engine, or something else?	FHIR R4 is the current standard; HL7v2-only integrations are older, more brittle, and usually mean a custom build per site.
Which specific FHIR resources do you read and write (Encounter, Patient, Condition, DocumentReference, etc.)?	A vague answer here usually means the integration hasn't been built past a pilot with one health system.
Have you completed a live integration with more than one EHR vendor, in production, with a named reference customer?	"Agnostic" without a second production reference is a roadmap claim, not a capability.

2. Integration timeline

The 12-to-18-month implementation window quoted by legacy, EHR-embedded tools is the default you should expect any modern platform to beat by a wide margin. A standards-based integration should be measured in weeks. If a vendor's timeline estimate sounds like an EHR vendor's timeline, ask why — the honest answer is often that the "AI layer" is actually a module built inside the EHR's own development environment, which inherits the EHR's release and testing cycle.

Questions to ask

What is the timeline from signed contract to a single unit going live, and what is the timeline to full-facility rollout?

What does your organization need to provide, and by when — IT staff hours, a sandbox environment, EHR admin approval, a security review?

Do you require a separate, paid professional-services engagement to complete the integration, or is implementation included?

Can we see a week-by-week implementation plan from a completed customer deployment, not a template?

What happens to the timeline if our EHR is on an older version, or if we run more than one EHR across facilities?

Who is our point of contact during implementation, and what's the escalation path if the timeline slips?

Red flags

The timeline estimate is a single number with no phase breakdown (e.g., "12 weeks") and no reference customer willing to confirm it.
The vendor can't describe what your IT team needs to do — a real integration always has dependencies on your side.
"Go-live" is defined as read-only access to a dashboard, not two-way integration with the EHR.

3. Data access

This is the section most buyers under-scope, because it sounds like an engineering question rather than a contract question. It's both. What data the platform can read, what it writes back, where it's stored, and what happens to it after the relationship ends should all be answered in writing — not inferred from the sales deck.

Questions to ask

Is data access read-only, or does the platform write back into the EHR? If it writes back, exactly which fields, and under whose clinical authority?

Where is protected health information (PHI) stored — in the vendor's cloud environment, a customer-controlled environment, or not persisted at all beyond the API call?

Is data encrypted in transit and at rest? What's the key management model, and who holds the keys?

Do you use our data — including de-identified or aggregated data — to train models that serve other customers? If so, can we opt out?

What's the data retention policy, and what is the process and timeline for full data deletion or export if we terminate the contract?

Can we get a full, structured export of everything the platform holds about our patients and operations, in a standard format, on request?

What audit logging exists for who accessed what data, when — and can our security team review those logs directly?

Does the platform require broad, standing access to the entire EHR, or scoped access to only the data elements the workflow actually needs?

The scoped-access question is the one most often skipped, and it's the one that matters most to your security team. A workflow tool that asks for narrow, purpose-built FHIR scopes under SMART on FHIR is a fundamentally different risk profile than one that asks for a standing, all-access service account into your EHR.

4. The BAA

Under HIPAA, any vendor that creates, receives, maintains, or transmits PHI on your behalf must sign a Business Associate Agreement (BAA) before that data ever flows. The BAA is not a formality to route to legal after the pilot is approved — its terms should shape whether you run the pilot with real patient data at all.

Questions to ask

Will you sign a BAA before any PHI is exchanged — including during a pilot or proof-of-concept?

Does the BAA cover every subcontractor and cloud infrastructure provider that will touch PHI, not just the vendor itself?

What are the vendor's breach notification timelines under the BAA, and are they faster than or equal to HIPAA's default 60-day requirement?

Who bears liability, and up to what limit, in the event of a data breach caused by the vendor's platform?

Does the BAA specify what happens to PHI upon contract termination — deletion, return, or continued retention for a defined legal-hold period?

Is the BAA a standard template you can share for review before the sales process goes further, or is it negotiated case-by-case?

Red flags

The vendor proposes starting a pilot with real patient data "informally" before the BAA is finalized.
The BAA doesn't name or flow down to the specific cloud subprocessors handling storage or compute.
Breach notification terms are vaguer or slower than what HIPAA already requires — the BAA should raise the floor, not just meet it.

5. Certifications worth asking about

Vendor security claims are only as good as the framework behind them. Ask which of the following the platform has, or is actively building toward, and ask for the assessment report or certificate — not just the logo on the website.

Ask for evidence of

HITRUST CSF certification — the healthcare-specific security framework built around HIPAA, NIST, and ISO controls; ask which version (e.g., v11.7.0) and what assessment type (self, validated, or certified via an external assessor).

SOC 2 Type II report — evidence controls were tested and operated effectively over a period of months, not just designed on paper.

Penetration testing cadence — how often, and by whom (an internal team, or an independent third party)?

SSO and role-based access control — can access be scoped by clinical role and integrated with your existing identity provider?

6. The one-page version

If you only bring six questions into the vendor meeting, bring these.

Show me a production integration with a second EHR vendor besides the one you built for first — not a roadmap item.
Give me a week-by-week implementation plan from a real customer, and the name of that customer.
Tell me exactly which data elements you read and write, and whether access is scoped or standing.
Will you sign the BAA before the pilot starts, and will it name every subprocessor that touches PHI?
What happens to our data — deletion, export, retention — the day this contract ends?
Send me your most recent SOC 2 Type II report and your HITRUST status, in writing, before the next call.

None of this is about catching vendors in a lie. Most of the vendors you'll talk to are building something real. The point of asking these questions early is that the answers — precise or evasive, documented or hand-waved — tell you more about how the platform will behave in production than any demo can.

Evaluating disposition intelligence platforms?

Happy to walk through how we answer each of these questions.

Get in touch